Gruijs, M., Ganzevles, S. H., Stigter-van Walsum, M., van der Mast, R., van Ostaijen-ten Dam, M. M., Tuk, C. W., . . . Bakema, J. E. (2021). NK Cell-Dependent Antibody-Mediated Immunotherapy Is Improved In Vitro and In Vivo When Combined with Agonists for Toll-like Receptor 2 in Head and Neck Cancer Models. International journal of molecular sciences, 22(20), 11057. https://doi.org/10.3390/ijms222011057
Citace podle Chicago (17th ed.)Gruijs, Mandy, et al. "NK Cell-Dependent Antibody-Mediated Immunotherapy Is Improved In Vitro and In Vivo When Combined with Agonists for Toll-like Receptor 2 in Head and Neck Cancer Models." International Journal of Molecular Sciences 22, no. 20 (2021): 11057. https://doi.org/10.3390/ijms222011057.
Citace podle MLA (9th ed.)Gruijs, Mandy, et al. "NK Cell-Dependent Antibody-Mediated Immunotherapy Is Improved In Vitro and In Vivo When Combined with Agonists for Toll-like Receptor 2 in Head and Neck Cancer Models." International Journal of Molecular Sciences, vol. 22, no. 20, 2021, p. 11057, https://doi.org/10.3390/ijms222011057.